Current low SARS-CoV-2 transmission, with U.S. emergency department visits at 0.1% and hospitalization rates of 0.2 per 100,000 as of early June 2026, underpins the market-implied 94% probability against a new coronavirus pandemic this year. Official CDC surveillance shows the BA.3.2 lineage and other Omicron subvariants circulating at low prevalence without driving excess morbidity, consistent with widespread population immunity from prior infections and updated vaccines. Rt estimates near 0.98 indicate stable or declining community spread across most states. Trader consensus reflects these verified epidemiological indicators and the absence of novel coronavirus emergence meeting pandemic criteria. However, zoonotic spillovers or variants with substantial immune escape could still shift trajectories if surveillance detects rapid increases in transmissibility or severity.